Early exposure of pregnant women to non‐steroidal anti‐inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study

Objective To assess the risk of preterm birth associated with nonsteroidal anti‐inflammatory drugs (NSAIDs), focusing on early exposure in the period from conception to 22 weeks of gestation (WG). Design National population‐based retrospective cohort study. Setting The French National Health Insuran...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJOG : an international journal of obstetrics and gynaecology 2021-09, Vol.128 (10), p.1575-1584
Hauptverfasser: Quantin, C, Yamdjieu Ngadeu, C, Cottenet, J, Escolano, S, Bechraoui‐Quantin, S, Rozenberg, P, Tubert‐Bitter, P, Gouyon, J‐B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1584
container_issue 10
container_start_page 1575
container_title BJOG : an international journal of obstetrics and gynaecology
container_volume 128
creator Quantin, C
Yamdjieu Ngadeu, C
Cottenet, J
Escolano, S
Bechraoui‐Quantin, S
Rozenberg, P
Tubert‐Bitter, P
Gouyon, J‐B
description Objective To assess the risk of preterm birth associated with nonsteroidal anti‐inflammatory drugs (NSAIDs), focusing on early exposure in the period from conception to 22 weeks of gestation (WG). Design National population‐based retrospective cohort study. Setting The French National Health Insurance Database that includes hospital discharge data and health claims data. Population Singleton pregnancies (2012–2014) with a live birth occurring after 22WG from women between 15 and 45 years old and insured the year before the first day of gestation and during pregnancy were included. We excluded pregnancies for which anti‐inflammatory medications were dispensed after 22WG. Methods The association between exposure and risk of preterm birth was evaluated with GEE models, adjusting on a large number of covariables, socio‐demographic variables, maternal comorbidities, prescription drugs and pregnancy complications. Main outcome measures Prematurity, defined as a birth that occurred before 37WG. Results Among our 1 598 330 singleton pregnancies, early exposure to non‐selective NSAIDs was associated with a significantly increased risk of preterm birth, regardless of the severity of prematurity: adjusted odds ratio (aOR) = 1.76 (95% CI 1.54–2.00) for extreme prematurity (95% CI 22–27WG), 1.28 (95% CI 1.17–1.40) for moderate prematurity (28–31WG) and 1.08 (95% CI 1.05–1.11) for late prematurity (32–36WG), with non‐overlapping confidence intervals. We identified five NSAIDs for which the risk of premature birth was significantly increased: ketoprofen, flurbiprofen, nabumetone, etodolac and indomethacin: for the latter, aOR = 1.92 (95% CI 1.37–2.70) with aOR = 9.33 (95% CI 3.75–23.22) for extreme prematurity. Conclusion Overall, non‐selective NSAID use (delivered outside hospitals) during the first 22WG was found to be associated with an increased risk of prematurity. However, the association differs among NSAIDs. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity.
doi_str_mv 10.1111/1471-0528.16670
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8451913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2561405427</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5010-d212999293d4eedabbc2910a7428aa3f7c94626ca859e0a44d25d3c6f9ea62223</originalsourceid><addsrcrecordid>eNqFkb9u1TAYxSMEoqVlZkOWmBjS-l-cmAGprUoLulKXMlu-sXPjktjBdu4lG4_AyuvxJHWacgUseLF1vnN-1qeTZa8QPEHpnCJaohwWuDpBjJXwSXa4V54-vGEOCa4Oshch3EGIGIbkeXZASMEhI_Qw-3kpfTcB_W1wYfQauAYMXm-stBHsXK8tiA5YZ399_xGi9s4o2YE0NEkwtulk38vo_ASUHzcBKN2ZrfZaATfGYJQGrQuDibILKaVmdqL0YG18bIE34cs7YGU0zu5mc-1a5yMIcVTTcfasSTH98vE-yj5_uLy9uM5XN1cfL85WeV1ABHOFEeacY04U1VrJ9brGHEFZUlxJSZqy5pRhVsuq4BpKShUuFKlZw7VkGGNylL1fuMO47rWqtY1edmLwppd-Ek4a8ffEmlZs3FZUtEAckQR4uwDaf2LXZysxa5BQiErOtih53zx-5t3XUYco7tzobdpP4IIhCguKy-Q6XVy1dyF43eyxCIq5dzG3LOaWxUPvKfH6zyX2_t9FJ0OxGHam09P_eOL8080CvgcLT72N</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561405427</pqid></control><display><type>article</type><title>Early exposure of pregnant women to non‐steroidal anti‐inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Quantin, C ; Yamdjieu Ngadeu, C ; Cottenet, J ; Escolano, S ; Bechraoui‐Quantin, S ; Rozenberg, P ; Tubert‐Bitter, P ; Gouyon, J‐B</creator><creatorcontrib>Quantin, C ; Yamdjieu Ngadeu, C ; Cottenet, J ; Escolano, S ; Bechraoui‐Quantin, S ; Rozenberg, P ; Tubert‐Bitter, P ; Gouyon, J‐B</creatorcontrib><description>Objective To assess the risk of preterm birth associated with nonsteroidal anti‐inflammatory drugs (NSAIDs), focusing on early exposure in the period from conception to 22 weeks of gestation (WG). Design National population‐based retrospective cohort study. Setting The French National Health Insurance Database that includes hospital discharge data and health claims data. Population Singleton pregnancies (2012–2014) with a live birth occurring after 22WG from women between 15 and 45 years old and insured the year before the first day of gestation and during pregnancy were included. We excluded pregnancies for which anti‐inflammatory medications were dispensed after 22WG. Methods The association between exposure and risk of preterm birth was evaluated with GEE models, adjusting on a large number of covariables, socio‐demographic variables, maternal comorbidities, prescription drugs and pregnancy complications. Main outcome measures Prematurity, defined as a birth that occurred before 37WG. Results Among our 1 598 330 singleton pregnancies, early exposure to non‐selective NSAIDs was associated with a significantly increased risk of preterm birth, regardless of the severity of prematurity: adjusted odds ratio (aOR) = 1.76 (95% CI 1.54–2.00) for extreme prematurity (95% CI 22–27WG), 1.28 (95% CI 1.17–1.40) for moderate prematurity (28–31WG) and 1.08 (95% CI 1.05–1.11) for late prematurity (32–36WG), with non‐overlapping confidence intervals. We identified five NSAIDs for which the risk of premature birth was significantly increased: ketoprofen, flurbiprofen, nabumetone, etodolac and indomethacin: for the latter, aOR = 1.92 (95% CI 1.37–2.70) with aOR = 9.33 (95% CI 3.75–23.22) for extreme prematurity. Conclusion Overall, non‐selective NSAID use (delivered outside hospitals) during the first 22WG was found to be associated with an increased risk of prematurity. However, the association differs among NSAIDs. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity.</description><identifier>ISSN: 1470-0328</identifier><identifier>EISSN: 1471-0528</identifier><identifier>DOI: 10.1111/1471-0528.16670</identifier><identifier>PMID: 33590634</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Cohort analysis ; Early exposure ; Flurbiprofen ; French National Health Insurance Database ; Gestation ; Gynecology and obstetrics ; Hospitals ; Human health and pathology ; Indomethacin ; Inflammation ; Life Sciences ; Nonsteroidal anti-inflammatory drugs ; non‐steroidal anti‐inflammatory drugs ; Original ; Pharmaceutical sciences ; Pharmacology ; Population studies ; Pregnancy ; Pregnancy complications ; Premature birth ; Prescription drugs ; risk of prematurity ; Santé publique et épidémiologie ; Womens health</subject><ispartof>BJOG : an international journal of obstetrics and gynaecology, 2021-09, Vol.128 (10), p.1575-1584</ispartof><rights>2021 The Authors. : An International Journal of Obstetrics and Gynaecology published by John Wiley &amp; Sons Ltd.</rights><rights>2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley &amp; Sons Ltd.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Attribution</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5010-d212999293d4eedabbc2910a7428aa3f7c94626ca859e0a44d25d3c6f9ea62223</citedby><cites>FETCH-LOGICAL-c5010-d212999293d4eedabbc2910a7428aa3f7c94626ca859e0a44d25d3c6f9ea62223</cites><orcidid>0000-0001-5134-9411 ; 0000-0002-6010-8238 ; 0000-0003-0864-4321 ; 0000-0003-4942-7753</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1471-0528.16670$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1471-0528.16670$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33590634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03401796$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Quantin, C</creatorcontrib><creatorcontrib>Yamdjieu Ngadeu, C</creatorcontrib><creatorcontrib>Cottenet, J</creatorcontrib><creatorcontrib>Escolano, S</creatorcontrib><creatorcontrib>Bechraoui‐Quantin, S</creatorcontrib><creatorcontrib>Rozenberg, P</creatorcontrib><creatorcontrib>Tubert‐Bitter, P</creatorcontrib><creatorcontrib>Gouyon, J‐B</creatorcontrib><title>Early exposure of pregnant women to non‐steroidal anti‐inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study</title><title>BJOG : an international journal of obstetrics and gynaecology</title><addtitle>BJOG</addtitle><description>Objective To assess the risk of preterm birth associated with nonsteroidal anti‐inflammatory drugs (NSAIDs), focusing on early exposure in the period from conception to 22 weeks of gestation (WG). Design National population‐based retrospective cohort study. Setting The French National Health Insurance Database that includes hospital discharge data and health claims data. Population Singleton pregnancies (2012–2014) with a live birth occurring after 22WG from women between 15 and 45 years old and insured the year before the first day of gestation and during pregnancy were included. We excluded pregnancies for which anti‐inflammatory medications were dispensed after 22WG. Methods The association between exposure and risk of preterm birth was evaluated with GEE models, adjusting on a large number of covariables, socio‐demographic variables, maternal comorbidities, prescription drugs and pregnancy complications. Main outcome measures Prematurity, defined as a birth that occurred before 37WG. Results Among our 1 598 330 singleton pregnancies, early exposure to non‐selective NSAIDs was associated with a significantly increased risk of preterm birth, regardless of the severity of prematurity: adjusted odds ratio (aOR) = 1.76 (95% CI 1.54–2.00) for extreme prematurity (95% CI 22–27WG), 1.28 (95% CI 1.17–1.40) for moderate prematurity (28–31WG) and 1.08 (95% CI 1.05–1.11) for late prematurity (32–36WG), with non‐overlapping confidence intervals. We identified five NSAIDs for which the risk of premature birth was significantly increased: ketoprofen, flurbiprofen, nabumetone, etodolac and indomethacin: for the latter, aOR = 1.92 (95% CI 1.37–2.70) with aOR = 9.33 (95% CI 3.75–23.22) for extreme prematurity. Conclusion Overall, non‐selective NSAID use (delivered outside hospitals) during the first 22WG was found to be associated with an increased risk of prematurity. However, the association differs among NSAIDs. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity.</description><subject>Cohort analysis</subject><subject>Early exposure</subject><subject>Flurbiprofen</subject><subject>French National Health Insurance Database</subject><subject>Gestation</subject><subject>Gynecology and obstetrics</subject><subject>Hospitals</subject><subject>Human health and pathology</subject><subject>Indomethacin</subject><subject>Inflammation</subject><subject>Life Sciences</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>non‐steroidal anti‐inflammatory drugs</subject><subject>Original</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacology</subject><subject>Population studies</subject><subject>Pregnancy</subject><subject>Pregnancy complications</subject><subject>Premature birth</subject><subject>Prescription drugs</subject><subject>risk of prematurity</subject><subject>Santé publique et épidémiologie</subject><subject>Womens health</subject><issn>1470-0328</issn><issn>1471-0528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqFkb9u1TAYxSMEoqVlZkOWmBjS-l-cmAGprUoLulKXMlu-sXPjktjBdu4lG4_AyuvxJHWacgUseLF1vnN-1qeTZa8QPEHpnCJaohwWuDpBjJXwSXa4V54-vGEOCa4Oshch3EGIGIbkeXZASMEhI_Qw-3kpfTcB_W1wYfQauAYMXm-stBHsXK8tiA5YZ399_xGi9s4o2YE0NEkwtulk38vo_ASUHzcBKN2ZrfZaATfGYJQGrQuDibILKaVmdqL0YG18bIE34cs7YGU0zu5mc-1a5yMIcVTTcfasSTH98vE-yj5_uLy9uM5XN1cfL85WeV1ABHOFEeacY04U1VrJ9brGHEFZUlxJSZqy5pRhVsuq4BpKShUuFKlZw7VkGGNylL1fuMO47rWqtY1edmLwppd-Ek4a8ffEmlZs3FZUtEAckQR4uwDaf2LXZysxa5BQiErOtih53zx-5t3XUYco7tzobdpP4IIhCguKy-Q6XVy1dyF43eyxCIq5dzG3LOaWxUPvKfH6zyX2_t9FJ0OxGHam09P_eOL8080CvgcLT72N</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Quantin, C</creator><creator>Yamdjieu Ngadeu, C</creator><creator>Cottenet, J</creator><creator>Escolano, S</creator><creator>Bechraoui‐Quantin, S</creator><creator>Rozenberg, P</creator><creator>Tubert‐Bitter, P</creator><creator>Gouyon, J‐B</creator><general>Wiley Subscription Services, Inc</general><general>Wiley</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5134-9411</orcidid><orcidid>https://orcid.org/0000-0002-6010-8238</orcidid><orcidid>https://orcid.org/0000-0003-0864-4321</orcidid><orcidid>https://orcid.org/0000-0003-4942-7753</orcidid></search><sort><creationdate>202109</creationdate><title>Early exposure of pregnant women to non‐steroidal anti‐inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study</title><author>Quantin, C ; Yamdjieu Ngadeu, C ; Cottenet, J ; Escolano, S ; Bechraoui‐Quantin, S ; Rozenberg, P ; Tubert‐Bitter, P ; Gouyon, J‐B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5010-d212999293d4eedabbc2910a7428aa3f7c94626ca859e0a44d25d3c6f9ea62223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cohort analysis</topic><topic>Early exposure</topic><topic>Flurbiprofen</topic><topic>French National Health Insurance Database</topic><topic>Gestation</topic><topic>Gynecology and obstetrics</topic><topic>Hospitals</topic><topic>Human health and pathology</topic><topic>Indomethacin</topic><topic>Inflammation</topic><topic>Life Sciences</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>non‐steroidal anti‐inflammatory drugs</topic><topic>Original</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacology</topic><topic>Population studies</topic><topic>Pregnancy</topic><topic>Pregnancy complications</topic><topic>Premature birth</topic><topic>Prescription drugs</topic><topic>risk of prematurity</topic><topic>Santé publique et épidémiologie</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quantin, C</creatorcontrib><creatorcontrib>Yamdjieu Ngadeu, C</creatorcontrib><creatorcontrib>Cottenet, J</creatorcontrib><creatorcontrib>Escolano, S</creatorcontrib><creatorcontrib>Bechraoui‐Quantin, S</creatorcontrib><creatorcontrib>Rozenberg, P</creatorcontrib><creatorcontrib>Tubert‐Bitter, P</creatorcontrib><creatorcontrib>Gouyon, J‐B</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quantin, C</au><au>Yamdjieu Ngadeu, C</au><au>Cottenet, J</au><au>Escolano, S</au><au>Bechraoui‐Quantin, S</au><au>Rozenberg, P</au><au>Tubert‐Bitter, P</au><au>Gouyon, J‐B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early exposure of pregnant women to non‐steroidal anti‐inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study</atitle><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle><addtitle>BJOG</addtitle><date>2021-09</date><risdate>2021</risdate><volume>128</volume><issue>10</issue><spage>1575</spage><epage>1584</epage><pages>1575-1584</pages><issn>1470-0328</issn><eissn>1471-0528</eissn><abstract>Objective To assess the risk of preterm birth associated with nonsteroidal anti‐inflammatory drugs (NSAIDs), focusing on early exposure in the period from conception to 22 weeks of gestation (WG). Design National population‐based retrospective cohort study. Setting The French National Health Insurance Database that includes hospital discharge data and health claims data. Population Singleton pregnancies (2012–2014) with a live birth occurring after 22WG from women between 15 and 45 years old and insured the year before the first day of gestation and during pregnancy were included. We excluded pregnancies for which anti‐inflammatory medications were dispensed after 22WG. Methods The association between exposure and risk of preterm birth was evaluated with GEE models, adjusting on a large number of covariables, socio‐demographic variables, maternal comorbidities, prescription drugs and pregnancy complications. Main outcome measures Prematurity, defined as a birth that occurred before 37WG. Results Among our 1 598 330 singleton pregnancies, early exposure to non‐selective NSAIDs was associated with a significantly increased risk of preterm birth, regardless of the severity of prematurity: adjusted odds ratio (aOR) = 1.76 (95% CI 1.54–2.00) for extreme prematurity (95% CI 22–27WG), 1.28 (95% CI 1.17–1.40) for moderate prematurity (28–31WG) and 1.08 (95% CI 1.05–1.11) for late prematurity (32–36WG), with non‐overlapping confidence intervals. We identified five NSAIDs for which the risk of premature birth was significantly increased: ketoprofen, flurbiprofen, nabumetone, etodolac and indomethacin: for the latter, aOR = 1.92 (95% CI 1.37–2.70) with aOR = 9.33 (95% CI 3.75–23.22) for extreme prematurity. Conclusion Overall, non‐selective NSAID use (delivered outside hospitals) during the first 22WG was found to be associated with an increased risk of prematurity. However, the association differs among NSAIDs. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity. Tweetable French study for which early exposure to non‐selective NSAIDs was associated with increased risk of prematurity.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33590634</pmid><doi>10.1111/1471-0528.16670</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-5134-9411</orcidid><orcidid>https://orcid.org/0000-0002-6010-8238</orcidid><orcidid>https://orcid.org/0000-0003-0864-4321</orcidid><orcidid>https://orcid.org/0000-0003-4942-7753</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1470-0328
ispartof BJOG : an international journal of obstetrics and gynaecology, 2021-09, Vol.128 (10), p.1575-1584
issn 1470-0328
1471-0528
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8451913
source Wiley Online Library Journals Frontfile Complete
subjects Cohort analysis
Early exposure
Flurbiprofen
French National Health Insurance Database
Gestation
Gynecology and obstetrics
Hospitals
Human health and pathology
Indomethacin
Inflammation
Life Sciences
Nonsteroidal anti-inflammatory drugs
non‐steroidal anti‐inflammatory drugs
Original
Pharmaceutical sciences
Pharmacology
Population studies
Pregnancy
Pregnancy complications
Premature birth
Prescription drugs
risk of prematurity
Santé publique et épidémiologie
Womens health
title Early exposure of pregnant women to non‐steroidal anti‐inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A30%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20exposure%20of%20pregnant%20women%20to%20non%E2%80%90steroidal%20anti%E2%80%90inflammatory%20drugs%20delivered%20outside%20hospitals%20and%20preterm%20birth%20risk:%20nationwide%20cohort%20study&rft.jtitle=BJOG%20:%20an%20international%20journal%20of%20obstetrics%20and%20gynaecology&rft.au=Quantin,%20C&rft.date=2021-09&rft.volume=128&rft.issue=10&rft.spage=1575&rft.epage=1584&rft.pages=1575-1584&rft.issn=1470-0328&rft.eissn=1471-0528&rft_id=info:doi/10.1111/1471-0528.16670&rft_dat=%3Cproquest_pubme%3E2561405427%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2561405427&rft_id=info:pmid/33590634&rfr_iscdi=true